Women’s health diagnostics holds immense importance in today's digital landscape. It ensures the authenticity of individuals, prevents fraud, and protects sensitive data. The applications of womens health diagnostics span across industries such as finance, e-commerce, healthcare, and government, enabling secure customer onboarding, regulatory compliance, and fraud prevention. Features include biometric authentication, document verification, and AI-driven algorithms for fraud detection. Women’s health diagnostics enhances security, builds trust, and improves user experience by providing seamless and reliable verification processes, protecting individuals' identities, and mitigating risks associated with identity theft and fraudulent activities.
Access Full Report at https://www.databridgemarketresearch.com/reports/global-womens-health-diagnostics-market
Data Bridge Market Research analyses that the Global Womens Health Diagnostics Market is valued at USD 27.10 billion in 2021 and is expected to reach USD 51.67 billion by 2029, registering a CAGR of 8.4% during the forecast period of 2022 to 2029. The rising incidence of gynecological disorders such as cervical cancer, breast cancer, ovarian disorders, and sexually transmitted infections (STIs) drives the demand for women's health diagnostics. Early detection and accurate diagnosis of these conditions are essential for effective treatment and improved patient outcomes.
Key Findings of the Study
Technological advancements is expected to drive the market's growth rate
The advancements in diagnostic technologies have revolutionized women's health diagnostics by enhancing accuracy, sensitivity, and speed of testing. Molecular diagnostics, such as DNA/RNA-based tests, enable precise detection of genetic mutations and biomarkers associated with conditions like breast and ovarian cancer. Next-generation sequencing allows comprehensive analysis of genetic information for personalized medicine. Point-of-care testing offers rapid and convenient on-site diagnostics, enabling immediate results for conditions like pregnancy, STIs, and hormone levels. These innovations have improved diagnostic capabilities, resulting in increased adoption and driving market growth in women's health diagnostics.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014-2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Diagnostic Devices (Imaging and Monitoring Systems, Biopsy Devices, Reagents and Kits, Biomarkers, Others), Application (Osteoporosis Testing, OVC Testing, Cervical Cancer Testing, Breast Cancer Testing, Pregnancy and Fertility Testing, Prenatal Genetic Screening and Carrier Testing, Infectious Disease Testing, STD Testing, Ultrasound Tests), End User (Hospitals, Diagnostic and Imaging Centers, Clinics, Home Care Setting)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Siemens (Germany), Hologic, Inc. (U.S.), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Abbott (U.S.), BD (US), F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific (U.S.), Koninklijke Philips N.V. (Netherlands), NeuroLogica Corp. (U.S.), Shimadzu Corporation (Japan), bioMérieux SA (France), Carestream Health (U.S.), MEDGYN PRODUCTS, INC. (U.S.), URIT MEDICAL ELECTRONIC CO., LTD (China), COOK (U.S.), Cardinal Health (U.S.), PerkinElmer Inc. (U.S.), General Electric Company (U.S.), Quest Diagnostics Incorporated (U.S.), Danaher (U.S.), Sysmex Corporation (Japan), Hitachi, Ltd. (Japan), Canon Inc. (Japan), FUJIFILM Holdings Corporation (Japan).
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework
|
Segment Analysis:
The womens health diagnostics market is segmented on the basis of diagnostics devices, application and end user.
- On the basis of diagnostics devices, global womens health diagnostics market is segmented into imaging and monitoring systems, biopsy devices, reagents and kits, biomarkers and others. In 2022, imaging and monitoring systems dominated the growing at the highest CAGR of 12.4% in the forecast period of 2022-2029 as these technologies provide detailed visualization of organs, tissues, and abnormalities, enabling accurate diagnosis and effective treatment planning.
In 2022, imaging and monitoring systems segment is dominating the diagnostics devices segment of the global womens health diagnostics market
In 2022, biopsy devices segment is dominating the market growing at the highest CAGR of 12.4% in the forecast period of 2022-2029as monitoring systems such as fetal monitors, which track the health and well-being of the fetus during pregnancy, are essential in obstetrics and gynecology. They help assess fetal heart rate, uterine contractions, and other vital parameters to ensure a healthy pregnancy and delivery.
- On the basis of application, the womens health diagnostics market is segmented into osteoporosis testing, OVC testing, cervical cancer testing, breast cancer testing, pregnancy and fertility testing, prenatal genetic screening and carrier testing, infectious disease testing, STD testing and ultrasound tests. In 2022, breast cancer testing segment is expected to dominate the market at CAGR 13.3% due to as breast cancer is one of the most prevalent and concerning health conditions among women worldwide.
In 2022, breast cancer testing is dominating the application of the global womens health diagnostics market
In 2022, breast cancer testing segment is dominating the application segment of the global womens health diagnostics market CAGR 13.3% as screening and diagnostic tests for breast cancer, such as mammography, molecular diagnostics, and genetic testing, play a vital role in early detection and effective treatment planning. The rising incidence of breast cancer, coupled with increasing awareness and initiatives for early detection, has led to a significant demand for breast cancer testing.
- On the basis of end user, global womens health diagnostics market is segmented into hospitals, diagnostic and imaging centers, clinics and home care setting. In 2022, hospitals segment is expected to dominate the global womens health diagnostics market in the forecast period of 2022 to 2029 as hospitals are the primary healthcare facilities where comprehensive diagnostic services are provided, including specialized tests for women's health conditions.
Major Players
Data Bridge Market Research recognizes the following companies as the major womens health diagnosticsmarket players in womens health diagnostics market are Siemens (Germany), Hologic, Inc. (U.S.), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Abbott (U.S.), BD (US), F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific (U.S.)
Market Development
- In September 2021, Terumo Aortic recently initiated a global surgical transplant research program called PANTHER. This comprehensive study involves both prospective and retrospective analysis conducted across multiple centers and arms. The research focuses on evaluating Terumo Aortic's complete range of knitted and woven surgical grafts, as well as cardiovascular patches.
- In February 2023, Genetic Technologies Limited, a prominent global player in genomics-based tests, introduced a groundbreaking comprehensive risk assessment test. This innovative test evaluates a woman's risk of breast and ovarian cancer, considering hereditary genetic mutations as well as familial or sporadic cancer. The test, utilizing a simple saliva sample, combines clinical risk factors for early detection and personalized treatment strategies.
- In June 2022, Indian diagnostics company Mylab Discovery Solutions made its entry into the women's healthcare segment by introducing PregaScreen, a home pregnancy test kit. Mylab plans to expand its product line with innovative and affordable solutions, targeting women of different age groups and aiming to become a significant player in the women's healthcare market.
Regional Analysis
Geographically, the countries covered in the womens health diagnostics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
As per Data Bridge Market Research analysis:
North America is the dominant region in womens health diagnostics market during the forecast period 2022 - 2029
In 2022, North America dominated the womens health diagnostics market due to increasing adoption of technologically advanced products. Innovations such as molecular diagnostics and next-generation sequencing have improved the accuracy and effectiveness of diagnostics in women's health. Additionally, government initiatives focused on women's health and the introduction of new product launches are anticipated to further drive market growth. These factors collectively contribute to the expansion of the women's health diagnostics market in the region during the forecast period.
Asia-Pacific is estimated to be the fastest growing region in womens health diagnostics market the forecast period 2022 - 2029
Asia-Pacific is expected to grow during the forecast period due to the improving healthcare infrastructure enables better access to diagnostic services for women. Government initiatives and policies aimed at promoting women's health, along with the increasing participation of women in the workforce, contribute to market growth. Additionally, the rising awareness regarding women's health disorders plays a significant role in driving the demand for women's health diagnostics. These factors combined are anticipated to fuel the growth of the women's health diagnostics market in the region in the forthcoming years.
For more detailed information about the womens health diagnostics market report, click here – https://www.databridgemarketresearch.com/reports/global-womens-health-diagnostics-market
